ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2024

Prediction of Adjuvant Gemcitabine Sensitivity in Resectable Pancreatic Adenocarcinoma Using the GemPred RNA Signature: An Ancillary Study of the PRODIGE-24/CCTG PA6 Clinical Trial.

Rémy Nicolle et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.